Finding Value Investments in Private Equity
Finding Value Investments in Private Equity
Private investors and venture capitalists are always looking for the next great company, idea or product to put their money into, in order to reap great financial rewards down the road. However, how do private investors know where to find the true value investments that exist?
Experienced Investor
Jonathan Coslet is the Chief Investment Officer at Texas Pacific Group, also known as TPG capital, and he has been with the firm since its inception in 1993. He also serves on TPG’s Executive Committee. Before joining TPG, Jonathan started his career at Drexel Burnham Lambert and later moved to Donaldson, Lufkin & Jenrette. His formal education includes earning a BS in economics and finance from the Wharton School of the University of Pennsylvania where he was Valedictorian and later he received his MBA from Harvard Business School, where he was a Baker Scholar. Jonathan currently serves on the Board of the Stanford Institute for Economic Policy Research, the Stanford Children’s Hospital and the Stanford Medical Advisory Council. Jonathan and I discussed TPG’s state of private equity, as the company currently has almost $80 billion under its management. So I asked Jonathan how he finds the value investments?
Working on the Fringe
“At the end of the day, we have to be what I call fringe capital. Private equity as a whole is maybe 5 percent of the entire equity market capital ecosystem. The public markets are very efficient. They are getting more and more efficient every day and therefore the return on that capital is going to be tighter. We have to play around the fringes. We have to see things that others don’t see and we have to be willing to do things that others won’t do.” Jonathan said his firm has to do two things around the fringes. He said they have to have a different or uncommon point of view as an investor, which means they have to specialize, which includes both industry specialization and geographical specialization.
A Change for the Better
The other thing they need to do, according to Jonathan is to change or improve companies once they own them. “We have to do the hard work, like we did at Continental Airlines, like we did at Burger King, like we did with so many other companies along the way. That often means changing management. It often means employing new operational and strategic approaches to companies that for whatever reason aren’t being managed in a way that is aligned with the shareholders’ way.” Jonathan then explained that when you have a different point of view as an investor and you can change companies, you can outperform. “It’s hard. It takes a lot of work and it takes a lot of capabilities that you develop over time, but that’s what we do.”
Be Honest With Yourself
Jonathan concluded by saying that you have to be very selective. If you realize that you don’t see it in a very different way from everyone else or you don’t think you can really change it then maybe it’s not worth the investment because you can’t add a lot of value to it, as opposed to the ones where you do have a different point of view and where you do have a different strategic approach to operational improvement.
Contact Us here
Armin Tahmasbi | Encapsulate
I’m a young entrepreneur and a Ph.D. candidate in Biomedical Engineering program at the University of Connecticut, working on “Drug Delivery Systems, Self-Assembled Nanoparticles & Microfluidic Devices”, in Storrs, CT, US. I’m working in Self-Assembled Functional Nanomaterials Laboratory, under the supervision of Prof. Mu-Ping Nieh on “Drug Delivery Systems for cancer therapy”. We’re developing a universal platform for encapsulating and smart delivery of a wide range of drug molecules and
Spencer Jones | Lineus Medical
Spencer worked for 3 years in direct patient care as a Certified Nursing Assistant, Licensed Practical Nurse, and as a Registered Nurse. Frustrated with the inefficiencies plaguing the healthcare system, he was determined to play a role in improving the delivery of healthcare. In 2014, Spencer won the annual ARK Challenge, an Arkansas based business accelerator. The product he developed was a dual lumen peripheral IV called the BVAD, which focuses on painless and uncontaminated blood draws.
Adeel Malik | CEO of Clearstep
While studying finance and neurobiology in undergrad, Adeel spent his time doing neuro-immunology research at the Johns Hopkins Hospital, contributing to several academic publications. After undergrad, Adeel was a strategy & analytics consultant with Accenture for several years where he worked with some of the largest institutions in healthcare across pharma, health tech, health systems, and retail clinics. Adeel’s skills in healthcare analytics, operations, sales, and his breadth of experience
Yael Katz | How BrainCheck is Democratizing Cognitive Health
Dr. Yael Katz is the co founder and CEO of Braincheck, a healthcare technology company focused on making cognitive health assessments more accessible. Prior to co founding Braincheck, Yael was VP of ecommerce at JW Player and a post doctoral research fellows at Princeton University. She received a Ph.D in in Biological Sciences focusing on Computational and Experimental Neuroscience from Northwestern University.Alan What brought you to co founding Braincheck? Yael If a person has a concern that